Beyond the Code: How DNA Nanotechnology is Moving from Molecular Origami to Programmable Biotech Platforms

DNA nanostructures can place proteins, ligands, fluorophores, or nanoparticles at defined distances and stoichiometries. This makes them powerful tools for studying the spatial organization of biological molecules: for example, to study the clustering of immune receptors during T-cell activation or the arrangement of enzymes in signaling cascades. 

For biotechnology, DNA nanostructures are interesting for applications that require fine spatial control, such as biosensing, diagnostics, and drug delivery. A growing number of biotech companies are exploring the potential of DNA nanotechnology, with research tools and diagnostics likely closest to commercial maturity. For example, biotech company GATTAquant already sells DNA origami-based calibration standards, while Amplifold is developing DNA origami-enhanced lateral-flow diagnostics and aims to obtain European In Vitro Diagnostic Medical Devices Regulation (IVDR) approval. Therapeutic applications are advancing as well, but remain substantially earlier in development. Cost, scalable manufacturing, stability in biological environments, and reproducible characterization remain key bottlenecks for the advancement of the technology. 

DNA as programmable material

DNA is usually understood as the molecule of heredity, but in DNA nanotechnology it becomes a designable construction material. Predictable base pairing allows researchers to encode not only sequence information, but also structural information, enabling increasingly complex and versatile structures.

DNA origami, introduced by Paul Rothemund in 2006, made it possible to fold complex two- and three-dimensional objects from a long scaffold strand and many short staple strands, with functional groups positioned at predetermined sites. Importantly, DNA nanostructures are not simply tiny objects; they are programmable frameworks in which specific sites can be assigned specific functions, such as holding fluorophores, presenting ligands, arranging enzymes, organizing nanoparticles, or interacting with proteins and membranes.

DNA nanotechnology can also encompass dynamic structures—for example, systems that undergo conformational switching, move along molecular tracks, or release cargo in response to a trigger. have demonstrated that DNA can act not only as a scaffold but also as an actuator. DNA’s molecular recognition properties also enable programmable assemblies that , with applications in in situ monitoring, drug delivery, and personalized medicine.